MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 144.11 Million EUR | -91.61% |
| 2022 | 571.9 Million EUR | 3.79% |
| 2021 | 551 Million EUR | 0.69% |
| 2020 | 547.2 Million EUR | -0.89% |
| 2019 | 552.1 Million EUR | 5.02% |
| 2018 | 525.7 Million EUR | 5.88% |
| 2017 | 496.49 Million EUR | 5.26% |
| 2016 | 471.66 Million EUR | 4.29% |
| 2015 | 452.28 Million EUR | 4.91% |
| 2014 | 431.09 Million EUR | 6.71% |
| 2013 | 404 Million EUR | 1.36% |
| 2012 | 398.58 Million EUR | 4.03% |
| 2011 | 383.12 Million EUR | 1.67% |
| 2010 | 376.83 Million EUR | 3.77% |
| 2009 | 363.16 Million EUR | 3.4% |
| 2008 | 351.2 Million EUR | 316.1% |
| 2007 | 84.4 Million EUR | 5.1% |
| 2006 | 80.31 Million EUR | -72.71% |
| 2005 | 294.29 Million EUR | -1.85% |
| 2004 | 299.82 Million EUR | -0.29% |
| 2003 | 300.68 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 20.81 Million EUR | 31.17% |
| 2024 Q1 | 15.87 Million EUR | 248.6% |
| 2023 Q4 | -10.68 Million EUR | -107.19% |
| 2023 Q2 | 153.99 Million EUR | 9.73% |
| 2023 Q3 | 148.48 Million EUR | -3.58% |
| 2023 Q1 | 140.34 Million EUR | -3.01% |
| 2023 FY | 47.98 Million EUR | -91.61% |
| 2022 Q3 | 137.18 Million EUR | -8.27% |
| 2022 FY | 571.9 Million EUR | 3.79% |
| 2022 Q1 | 140.45 Million EUR | -0.97% |
| 2022 Q4 | 144.7 Million EUR | 5.48% |
| 2022 Q2 | 149.55 Million EUR | 6.48% |
| 2021 Q1 | 127.88 Million EUR | -4.56% |
| 2021 Q2 | 136.43 Million EUR | 6.69% |
| 2021 Q3 | 144.85 Million EUR | 6.17% |
| 2021 Q4 | 141.82 Million EUR | -2.09% |
| 2021 FY | 551 Million EUR | 0.69% |
| 2020 Q4 | 133.99 Million EUR | -7.8% |
| 2020 FY | 547.2 Million EUR | -0.89% |
| 2020 Q3 | 145.33 Million EUR | 12.17% |
| 2020 Q2 | 129.57 Million EUR | -6.31% |
| 2020 Q1 | 138.29 Million EUR | -0.24% |
| 2019 Q2 | 137.16 Million EUR | -0.85% |
| 2019 Q4 | 138.62 Million EUR | 0.47% |
| 2019 FY | 552.1 Million EUR | 5.02% |
| 2019 Q1 | 138.33 Million EUR | 10.12% |
| 2019 Q3 | 137.96 Million EUR | 0.58% |
| 2018 Q4 | 125.62 Million EUR | -7.29% |
| 2018 FY | 525.7 Million EUR | 5.88% |
| 2018 Q1 | 129.66 Million EUR | 1.44% |
| 2018 Q2 | 134.65 Million EUR | 3.85% |
| 2018 Q3 | 135.5 Million EUR | 0.63% |
| 2017 Q4 | 127.82 Million EUR | 2.39% |
| 2017 Q3 | 124.83 Million EUR | 0.38% |
| 2017 Q2 | 124.36 Million EUR | 4.09% |
| 2017 Q1 | 119.47 Million EUR | 1.94% |
| 2017 FY | 496.49 Million EUR | 5.26% |
| 2016 Q1 | 115.46 Million EUR | 0.59% |
| 2016 Q2 | 120.12 Million EUR | 4.04% |
| 2016 Q3 | 118.87 Million EUR | -1.04% |
| 2016 Q4 | 117.2 Million EUR | -1.41% |
| 2016 FY | 471.66 Million EUR | 4.29% |
| 2015 Q4 | 114.78 Million EUR | 0.14% |
| 2015 FY | 452.28 Million EUR | 4.91% |
| 2015 Q3 | 114.62 Million EUR | 2.12% |
| 2015 Q2 | 112.25 Million EUR | 1.48% |
| 2015 Q1 | 110.61 Million EUR | 2.11% |
| 2014 Q2 | 108.08 Million EUR | 3.73% |
| 2014 Q1 | 104.19 Million EUR | 6.6% |
| 2014 Q4 | 108.33 Million EUR | -1.95% |
| 2014 Q3 | 110.48 Million EUR | 2.22% |
| 2014 FY | 431.09 Million EUR | 6.71% |
| 2013 Q2 | 104.74 Million EUR | 8.71% |
| 2013 Q4 | 97.74 Million EUR | -7.05% |
| 2013 FY | 404 Million EUR | 1.36% |
| 2013 Q1 | 96.34 Million EUR | -1.22% |
| 2013 Q3 | 105.16 Million EUR | 0.4% |
| 2012 Q2 | 101 Million EUR | 3.04% |
| 2012 Q3 | 102.02 Million EUR | 1.01% |
| 2012 Q4 | 97.53 Million EUR | -4.4% |
| 2012 FY | 398.58 Million EUR | 4.03% |
| 2012 Q1 | 98.02 Million EUR | 0.68% |
| 2011 Q2 | 188.68 Million EUR | 102.77% |
| 2011 Q4 | 97.35 Million EUR | 0.28% |
| 2011 Q1 | 93.05 Million EUR | -2.39% |
| 2011 FY | 383.12 Million EUR | 1.67% |
| 2011 Q3 | 97.08 Million EUR | -48.54% |
| 2010 Q4 | 95.32 Million EUR | 0.82% |
| 2010 Q3 | 94.54 Million EUR | -1.32% |
| 2010 Q2 | 95.8 Million EUR | 5.1% |
| 2010 Q1 | 91.15 Million EUR | -1.97% |
| 2010 FY | 376.83 Million EUR | 3.77% |
| 2009 Q4 | 92.99 Million EUR | 0.12% |
| 2009 FY | 363.16 Million EUR | 3.4% |
| 2009 Q1 | 85.68 Million EUR | 0.0% |
| 2009 Q3 | 92.88 Million EUR | 1.39% |
| 2009 Q2 | 91.6 Million EUR | 6.91% |
| 2008 FY | 351.2 Million EUR | 316.1% |
| 2007 FY | 84.4 Million EUR | 5.1% |
| 2006 FY | 80.31 Million EUR | -72.71% |
| 2005 FY | 294.29 Million EUR | -1.85% |
| 2004 FY | 299.82 Million EUR | -0.29% |
| 2003 FY | 300.68 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 4.92 Billion EUR | 97.074% |
| Fresenius SE & Co. KGaA | 5.05 Billion EUR | 97.151% |
| LIMES Schlosskliniken AG | 13.58 Million EUR | -960.837% |
| M1 Kliniken AG | 26.66 Million EUR | -440.516% |
| Maternus-Kliniken Aktiengesellschaft | 11.9 Million EUR | -1110.864% |
| RHÖN-KLINIKUM Aktiengesellschaft | 198.49 Million EUR | 27.393% |
| VITA 34 AG | 28.24 Million EUR | -410.257% |